Discounted Cash Flow
Novavax Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $15.4m | $-280.0m | $-273.7m | -1823.5% | $-1.03 |
| 2017 | $31.2m (103.1%) | $-183.8m (34.4%) | $-142.9m (47.8%) | -589.5% (67.7%) | $-0.63 (38.8%) |
| 2018 | $34.3m (10.0%) | $-184.7m (-0.5%) | $-186.2m (-30.3%) | -538.8% (8.6%) | $-0.50 (20.6%) |
| 2019 | $18.7m (-45.6%) | $-132.7m (28.2%) | $-138.5m (25.6%) | -711.0% (-32.0%) | $-5.51 (-1002.0%) |
| 2020 | $475.6m (2448.5%) | $-418.3m (-215.2%) | $-97.2m (29.8%) | -87.9% (87.6%) | $-7.27 (-31.9%) |
| 2021 | $1.1b (141.0%) | $-1.7b (-316.9%) | $265.5m (373.2%) | -152.1% (-73.0%) | $-23.44 (-222.4%) |
| 2022 | $2.0b (72.9%) | $-657.9m (62.3%) | $-508.9m (-291.7%) | -33.2% (78.2%) | $-8.42 (64.1%) |
| 2023 | $983.7m (-50.4%) | $-545.1m (17.2%) | $-772.8m (-51.8%) | -55.4% (-66.9%) | $-5.41 (35.7%) |
| 2024 | $682.2m (-30.7%) | $-187.5m (65.6%) | $-101.9m (86.8%) | -27.5% (50.4%) | $-1.23 (77.3%) |
| 2025 | $1.1b (64.7%) | $440.3m (334.8%) | $-251.0m (-146.3%) | 39.2% (242.6%) | $2.72 (321.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.